# A Study of NOV140201 (JPI-547) in Subject With Advanced Solid Tumors

> **NCT04335604** · PHASE1 · COMPLETED · sponsor: **Onconic Therapeutics Inc.** · enrollment: 62 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** JPI-547

## Key facts

- **NCT ID:** NCT04335604
- **Lead sponsor:** Onconic Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-06
- **Primary completion:** 2021-12-14
- **Final completion:** 2021-12-14
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2022-06-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04335604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04335604, "A Study of NOV140201 (JPI-547) in Subject With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04335604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*